Ocular Therapeutix, Inc. (OCUL)
8.415
+0.64
(+8.16%)
USD |
NASDAQ |
Feb 23, 16:00
8.44
+0.02
(+0.30%)
After-Hours: 19:59
Ocular Therapeutix Profit Margin (Quarterly) : -488.0% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Boston Scientific Corp. | 12.68% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| EyePoint Plc | -6.18K% |
| Vertex Pharmaceuticals, Inc. | 36.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -73.88% |
| Return on Assets | -52.41% |
| Return on Invested Capital | -60.92% |
| Gross Profit Margin (Quarterly) | 87.97% |
| Operating Margin (Quarterly) | -526.5% |
| Return on Net Operating Assets | -510.0% |